|
Volumn 42, Issue 4, 2010, Pages 1281-1282
|
Extracorporeal Circulatory Support for Lung Transplantation: Institutional Experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOBUTAMINE;
NITRIC OXIDE;
PROSTAGLANDIN E1;
ARTICLE;
ASSISTED CIRCULATION;
BLEEDING;
BRONCHIECTASIS;
BRONCHITIS;
CARDIOPULMONARY BYPASS;
CAUSE OF DEATH;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONTROLLED STUDY;
CYSTIC FIBROSIS;
EXTRACORPOREAL CIRCULATION;
GRAFT DYSFUNCTION;
GRAFT FAILURE;
HIGH RISK PATIENT;
HUMAN;
LUNG ARTERY PRESSURE;
LUNG FIBROSIS;
LUNG INSUFFICIENCY;
LUNG TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MORBIDITY;
MULTIPLE ORGAN FAILURE;
PATIENT SELECTION;
PEROPERATIVE CARE;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RETRANSPLANTATION;
RISK ASSESSMENT;
SURGICAL MORTALITY;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT INDICATION;
TREATMENT PLANNING;
TREATMENT RESPONSE;
BRONCHIECTASIS;
CARDIOPULMONARY BYPASS;
CYSTIC FIBROSIS;
HUMANS;
HYPERTENSION, PULMONARY;
INTRAOPERATIVE PERIOD;
LITHIASIS;
LUNG DISEASES;
LUNG TRANSPLANTATION;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
PULMONARY FIBROSIS;
RISK ASSESSMENT;
SURVIVAL RATE;
|
EID: 77952559787
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.03.114 Document Type: Article |
Times cited : (19)
|
References (9)
|